David Platt bought $198k of BIXT
CEO at BIOXYTRAN, INC. 1,592,921 shares at an average of $0.12, traded Aug 15, 2024, filed Aug 20, 2024.
Score components
- +25RoleCEO
- +12Trade size$198k at market
- +3Relative to holdingsHoldings up 8%
- +8Price context67% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -0.3%, 3m -7.0%, 6m -14.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001754429-24-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 15, 2024 | POpen-market purchase commonindirect: by NDPD Pharma | +1,592,921 | $0.12 | $198k | 21,675,939 | Aug 20, 2024 |
| Aug 19, 2024 | JOther commonindirect: by NDPD Pharma | -21,675,939 | $0.16 | $3.5M | 0 | Aug 20, 2024 |
| Aug 19, 2024 | JOther preferredindirect: by NDPD Pharma | +4,335,188 | $0.81 | $3.5M | 4,335,188 | Aug 20, 2024 |
| Aug 19, 2024 | CConversion preferredindirect: by NDPD Pharma | +8,973,405 | $0.02 | $162k | 13,308,593 | Aug 20, 2024 |
| Aug 19, 2024 | JOther preferredindirect: by NDPD Pharma | +776,817 | $0.46 | $354k | 14,085,410 | Aug 20, 2024 |
| Aug 19, 2024 | JOther commonindirect: by Naomi Platt | -411,300 | $0.00 | $411 | 0 | Aug 20, 2024 |
| Aug 19, 2024 | JOther preferredindirect: by Naomi Platt | +82,260 | $0.01 | $411 | 82,260 | Aug 20, 2024 |
| Aug 19, 2024 | JOther common | -43,027,274 | $0.00 | $43k | 0 | Aug 20, 2024 |
| Aug 19, 2024 | JOther preferred | +8,605,455 | $0.01 | $43k | 8,605,455 | Aug 20, 2024 |
Related signals
Other insiders at BIOXYTRAN, INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 34Weak | BIXTbuy BIOXYTRAN, INC | Alan M Hoberman director | $126k 210,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.